Key result
Dexmedetomidine effectively suppresses the cardiovascular response to laryngoscopy and intubation during general anesthesia by reducing heart rate, systolic blood pressure, and mean arterial pressure.
Why the study?
Endotracheal intubation during general anesthesia can trigger dangerous cardiovascular responses such as increased blood pressure and heart rate, leading to the use of methods like dexmedetomidine to control this response.
Does dexmedetomidine reduce cardiovascular response in patients undergoing endotracheal intubation during general anesthesia?
Does dexmedetomidine reduce cardiovascular response in patients undergoing endotracheal intubation during general anesthesia?
Dexmedetomidine effectively suppresses the cardiovascular response, including increases in heart rate and blood pressure, triggered by endotracheal intubation.
Answers are grounded in this paper and cite their sources.
May blunt intubation hemodynamic surges in select patients; leaves open optimal dosing and safety in cardiac cohorts.
Endotracheal intubation is commonly used to maintain a safe airway during general anesthesia. This intubation action can trigger a dangerous response for the patient, one of which is the cardiovascular system. Increases in arterial blood pressure, plasma catecholamine levels, and heart rate are responses that can occur during intubation. Therefore, various methods and treatments have been used to control this cardiovascular response, including dexmedetomidine. Dexmedetomidine is a highly selective α2-adrenergic receptor agonist that has analgesic, sympatholytic, and sedative effects with minimal depression of ventilation. Much research has been done on how well dexmedetomidine works to stop the cardiovascular response to intubation. Dexmedetomidine was significantly associated with reductions in heart rate, systolic blood pressure, and MAP.
No takes yet. Share an insight, caveat, or question.
Zulfikar Zulfikar (2024) conducted a review in Cardiovascular response due to intubation in general anesthesia. Dexmedetomidine vs. Fentanyl or Placebo was evaluated on Cardiovascular response (heart rate, systolic blood pressure, mean arterial pressure). Dexmedetomidine effectively suppresses the cardiovascular response to laryngoscopy and intubation during general anesthesia by reducing heart rate, systolic blood pressure, and mean arterial pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: